IM Cannabis (IMCC) Cash from Investing Activities (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Cash from Investing Activities of $312829.2 for Q1 2026, down 20.25% quarter-over-quarter from $392246.2 in Q4 2025.
IM Cannabis (IMCC) Cash from Investing Activities (2020 - 2026) Analysis & Trends
IM Cannabis' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $312829.2 for Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to $312829.2; the TTM figure through Mar 2026 stood at -$766373.0 (changed N/A YoY), while the FY2025 annual figure was -$380772.8, down 10.92% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $312829.2, down from $392246.2 in the prior quarter.
- The five-year high for Cash from Investing Activities was $1.1 million in Q3 2022, with the low at -$1.7 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$145507.9 (2024), against an average of -$172117.6.
- Peak annual rise in Cash from Investing Activities reached 158.17% in 2025, while the deepest fall reached 224.99% in 2025.
- IM Cannabis' Cash from Investing Activities stood at -$1.7 million in 2022, then jumped by 73.41% to -$462022.8 in 2023, then tumbled by 45.95% to -$674329.9 in 2024, then surged by 158.17% to $392246.2 in 2025, then dropped by 20.25% to $312829.2 in 2026.
- Business Quant data shows IMCC's Cash from Investing Activities at $312829.2 in Q1 2026, $392246.2 in Q4 2025, and -$797118.6 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | 16,627.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16,627.28 |
| Jun 30, 2026 | 16,627.28 |
| Mar 31, 2026 | 312,829.24 |
| Mar 31, 2026 | 312,829.24 |
| Dec 31, 2025 | 392,246.20 |
| Dec 31, 2025 | 392,246.20 |
| Sep 30, 2025 | -797,118.60 |
| Sep 30, 2025 | -797,118.60 |
| Dec 31, 2024 | -674,329.89 |
| Dec 31, 2024 | -674,329.89 |
| Sep 30, 2024 | 637,756.47 |
| Sep 30, 2024 | 637,756.47 |
| Jun 30, 2024 | -289,531.66 |
| Jun 30, 2024 | -289,531.66 |
| Mar 31, 2024 | -1,484.23 |
| Mar 31, 2024 | -1,484.23 |
| Dec 31, 2023 | -462,022.85 |
| Dec 31, 2023 | -462,022.85 |
| Jun 30, 2023 | -759,341.51 |
| Jun 30, 2023 | -759,341.51 |